Advertisement
Screener

HEPION PHARMACEUTICALS, INC. (HEPA) Deferred Tax Assets, Goodwill and Intangible Assets

1.6 / 5 stars · 19/59 Roast Me

HEPION PHARMACEUTICALS, INC. Deferred Tax Assets, Goodwill and Intangible Assets

HEPION PHARMACEUTICALS, INC. (HEPA) had Deferred Tax Assets, Goodwill and Intangible Assets of $113.21 thousand as of 2025-12-31, per its 10-K filed 2026-03-12.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-03-12

  • 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $113.21K.
Period endDeferred Tax Assets, Goodwill and Intangible Assets
2025-12-31$113.21K
10-K · filed 2026-03-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
NANOVIRICIDES, INC. (NNVC)United States$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
NextCure, Inc. (NXTC)United States$0.024B-0.15
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87